ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...

While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

Enveda, a biotechnology company using AI to translate nature into new medicines, announced today that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) ...

Dermatological drugs are a category of medications used to treat a wide range of skin conditions, including acne, eczema, psoriasis, fungal infections, and dermatitis ... In addition to topical ...

Parents of children with atopic dermatitis (AD, also called eczema) know that the allergic condition can ... "Elimination diets aren't recommended as a treatment for AD, according to guidelines from ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...

In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today its engagement in a collaboration with the SKIN Research ...

Pfizer showcased new treatments for atopic dermatitis, the leading type of eczema, at the 7th China International Import Expo ...

Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.

Medically reviewed by Katlein Franca, MD Eczema (atopic dermatitis) is a common skin condition that causes an itchy, inflamed ...

TD Cowen analyst Tyler Van Buren maintained a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report) today and set a price target ...